Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Pacific Biosciences of California Inc’s current trading price is -53.68% away from its 52-week high, while its distance from the 52-week low is 48.04%. The stock’s price range during this period has varied between $0.85 and $2.72. The company, active in the Healthcare sector, saw a trading volume of around 8.57 million for the day, considerably lower average daily volume of 9.26 million observed over the last three months.
Pacific Biosciences of California Inc (PACB) has a current stock price of $1.26. During the previous trading session, the stock witnessed a notable rise, reaching a high of $3.0 after opening at $1.26. The stock’s low for the day was $1.25, and it eventually closed at $1.35.
Pacific Biosciences of California Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $2.72 on 11/07/24, with the lowest value being $0.85 on 05/28/25.
How Financial Performance Impacts Market Capitalization
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 12.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 378.47M and boasts a workforce of 575 employees.
Decoding Analysts’ Ratings for Pacific Biosciences of California Inc
As of right now, 4 analysts are rating Pacific Biosciences of California Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2510, with a change in price of +0.0400. Similarly, Pacific Biosciences of California Inc recorded 8,741,834 in trading volume during the last 100 days, posting a change of +3.28%.
How PACB’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 11.37. Similarly, the long-term debt-to-equity ratio is also 11.36.
PACB Stock Stochastic Average
As of today, the raw stochastic average of Pacific Biosciences of California Inc over the last 50 days is at 37.50%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 5.66%. Further, the company’s Stochastic %K and %D values for the last 20 days were 9.08% and 12.97%, respectively.
PACB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -17.65% this year. Over the last six months, there has been a stronger performance of -19.23%. The price of PACB leaped by -14.29% during the last 30 days period. For the last 5-days stocks have slided -9.35%.
